NASDAQ : MYGN
Myriad Genetics, Inc. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 6.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 637.98M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Myriad Genetics, Inc. (MYGN) reported revenue of 806.60M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 806.60M | 824.50M | 837.60M | 753.20M | 678.40M | 690.60M |
| Cost of Revenue | 251.40M | 247.90M | 252.20M | 236.20M | 202.00M | 197.60M |
| Gross Profit | 555.20M | 576.60M | 585.40M | 517.00M | 476.40M | 493.00M |
| Selling, General & Admin | 539.90M | 537.60M | 560.00M | 572.90M | 514.70M | 537.80M |
| Research & Development | 105.80M | 106.80M | 113.40M | 88.70M | 85.40M | 81.90M |
| Operating Expenses | 645.70M | 644.40M | 673.40M | 661.60M | 600.10M | 619.70M |
| Operating Income | -90.50M | -67.80M | -88.00M | -144.60M | -123.70M | -126.70M |
| Interest Expense | -16.40M | -10.50M | -2.80M | -2.90M | -3.20M | -6.60M |
| Interest & Investment Income | 2.40M | 1.80M | 1.70M | 2.50M | 2.60M | 700.00K |
| Other Non Operating Income (Expenses) | 800.00K | 800.00K | 1.10M | -4.40M | 600.00K | -600.00K |
| EBT Excluding Unusual Items | -103.70M | -75.70M | -88.00M | -149.40M | -123.70M | -133.20M |
| Impairment of Goodwill | -4.50M | -234.70M | -16.90M | -1.80M | ||
| Gain (Loss) on Sale of Assets | -13.80M | 151.60M | ||||
| Asset Writedown | -3.60M | -84.70M | -43.00M | |||
| Legal Settlements | 21.30M | -112.80M | -62.00M | |||
| Other Unusual Items | -11.70M | |||||
| Pretax Income | -111.80M | -395.10M | -123.50M | -262.20M | -140.60M | -57.10M |
| Income Tax Expense | 800.00K | -29.20M | 3.80M | 1.10M | -28.60M | -29.90M |
| Earnings From Continuing Operations | -112.60M | -365.90M | -127.30M | -263.30M | -112.00M | -27.20M |
| Net Income | -112.60M | -365.90M | -127.30M | -263.30M | -112.00M | -27.20M |
| Net Income to Common | -112.60M | -365.90M | -127.30M | -263.30M | -112.00M | -27.20M |
| Shares Outstanding (Basic) | 93.70M | 92.60M | 90.60M | 82.80M | 80.60M | 78.00M |
| Shares Outstanding (Diluted) | 93.70M | 92.60M | 90.60M | 82.80M | 80.60M | 78.00M |
| EPS (Basic) | -1.20 | -3.95 | -1.41 | -3.18 | -1.39 | -0.35 |
| EPS (Diluted) | -1.20 | -3.95 | -1.41 | -3.18 | -1.39 | -0.35 |
| Free Cash Flow | -7.30M | -13.80M | -27.70M | -174.10M | -151.60M | 600.00K |
| Free Cash Flow Per Share | -0.08 | -0.15 | -0.31 | -2.10 | -1.88 | 0.01 |
| Gross Margin | 68.83% | 69.93% | 69.89% | 68.64% | 70.22% | 71.39% |
| Operating Margin | -11.22% | -8.22% | -10.51% | -19.20% | -18.23% | -18.35% |
| Profit Margin | -13.96% | -44.38% | -15.20% | -34.96% | -16.51% | -3.94% |
| Free Cash Flow Margin | -0.91% | -1.67% | -3.31% | -23.11% | -22.35% | 0.09% |
| EBITDA | -40.30M | -14.10M | -26.80M | -82.70M | -71.00M | -63.90M |
| EBITDA Margin | -5.00% | -1.71% | -3.20% | -10.98% | -10.47% | -9.25% |
| D&A For EBITDA | 50.20M | 53.70M | 61.20M | 61.90M | 52.70M | 62.80M |
| EBIT | -90.50M | -67.80M | -88.00M | -144.60M | -123.70M | -126.70M |
| EBIT Margin | -11.22% | -8.22% | -10.51% | -19.20% | -18.23% | -18.35% |
| Revenue as Reported | 690.60M | |||||
| Advertising Expenses | 10.10M | 10.30M | 8.50M | 5.30M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 115.20M | 149.60M | 102.40M | 132.10M | 56.90M | 257.40M |
| Short-Term Investments | 8.80M | 58.00M | 81.40M | |||
| Cash & Short-Term Investments | 115.20M | 149.60M | 102.40M | 140.90M | 114.90M | 338.80M |
| Accounts Receivable | 109.50M | 115.30M | 121.20M | 114.30M | 101.60M | 91.30M |
| Receivables | 109.50M | 115.30M | 121.20M | 114.30M | 101.60M | 91.30M |
| Inventory | 30.60M | 30.60M | 27.50M | 22.00M | 20.10M | 15.30M |
| Prepaid Expenses | 33.70M | 35.40M | 37.40M | 35.20M | 36.00M | 39.40M |
| Restricted Cash | 1.70M | 9.50M | 1.20M | 2.00M | ||
| Total Current Assets | 289.00M | 332.60M | 298.00M | 313.60M | 274.60M | 484.80M |
| Property, Plant & Equipment | 158.90M | 163.40M | 172.40M | 180.60M | 187.30M | 125.30M |
| Long-Term Investments | 54.80M | 59.00M | ||||
| Goodwill | 47.10M | 51.60M | 286.30M | 287.40M | 286.80M | 239.20M |
| Other Intangible Assets | 139.00M | 153.40M | 262.40M | 354.10M | 386.80M | 410.80M |
| Other Long-Term Assets | 4.90M | 5.60M | 8.50M | 10.80M | 8.40M | 1.60M |
| Total Assets | 638.90M | 706.60M | 1.03B | 1.15B | 1.20B | 1.32B |
| Accounts Payable | 30.40M | 30.00M | 32.30M | 25.80M | 28.80M | 29.60M |
| Accrued Expenses | 64.70M | 71.30M | 86.50M | 75.70M | 70.20M | 82.70M |
| Current Portion of Leases | 7.30M | 6.90M | 12.80M | 16.20M | 14.10M | 13.00M |
| Current Income Taxes Payable | 6.80M | 5.70M | 5.10M | 4.60M | 4.80M | 4.00M |
| Other Current Liabilities | 21.50M | 19.90M | 27.40M | 33.60M | 19.30M | 75.00M |
| Total Current Liabilities | 130.70M | 133.80M | 164.10M | 155.90M | 137.20M | 204.30M |
| Long-Term Debt | 120.70M | 119.90M | 39.60M | 38.50M | ||
| Long-Term Leases | 82.50M | 83.00M | 87.90M | 97.40M | 130.90M | 79.30M |
| Long-Term Deferred Tax Liabilities | 35.80M | |||||
| Other Long-Term Liabilities | 1.10M | 1.90M | 34.90M | 71.50M | 44.80M | 33.50M |
| Total Liabilities | 335.00M | 338.60M | 326.50M | 363.30M | 312.90M | 352.90M |
| Common Stock | 1.00M | 900.00K | 900.00K | 900.00K | 800.00K | 800.00K |
| Additional Paid-In Capital | 1.50B | 1.49B | 1.46B | 1.42B | 1.26B | 1.23B |
| Retained Earnings | -1.20B | -1.12B | -756.80M | -629.50M | -366.20M | -254.20M |
| Comprehensive Income & Other | 800.00K | 800.00K | -800.00K | -3.70M | -8.90M | -5.10M |
| Total Common Equity | 303.90M | 368.00M | 701.10M | 783.20M | 885.80M | 967.80M |
| Shareholders' Equity | 303.90M | 368.00M | 701.10M | 783.20M | 885.80M | 967.80M |
| Total Liabilities & Equity | 638.90M | 706.60M | 1.03B | 1.15B | 1.20B | 1.32B |
| Total Debt | 210.50M | 209.80M | 140.30M | 152.10M | 145.00M | 92.30M |
| Net Cash (Debt) | -95.30M | -60.20M | -37.90M | -11.20M | 24.70M | 305.50M |
| Net Cash Per Share | -1.02 | -0.65 | -0.42 | -0.14 | 0.31 | 3.92 |
| Filing Date Shares Outstanding | 95.65M | 93.51M | 91.31M | 89.87M | 81.22M | 80.02M |
| Total Common Shares Outstanding | 95.60M | 93.50M | 91.30M | 89.90M | 81.20M | 80.00M |
| Working Capital | 158.30M | 198.80M | 133.90M | 157.70M | 137.40M | 280.50M |
| Book Value Per Share | 3.18 | 3.94 | 7.68 | 8.71 | 10.91 | 12.10 |
| Tangible Book Value | 117.80M | 163.00M | 152.40M | 141.70M | 212.20M | 317.80M |
| Tangible Book Value Per Share | 1.23 | 1.74 | 1.67 | 1.58 | 2.61 | 3.97 |
| Machinery | 122.40M | 121.50M | 148.50M | 147.60M | 124.70M | 112.40M |
| Leasehold Improvements | 78.20M | 80.40M | 78.50M | 91.30M | 67.90M | 38.00M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -112.60M | -365.90M | -127.30M | -263.30M | -112.00M | -27.20M |
| Depreciation & Amortization | 50.20M | 53.70M | 61.20M | 61.90M | 52.70M | 62.80M |
| Loss (Gain) From Sale of Assets | -162.00M | |||||
| Asset Writedown & Restructuring Costs | 8.10M | 319.40M | 56.60M | 16.90M | 1.80M | |
| Stock-Based Compensation | 28.70M | 35.20M | 49.80M | 40.70M | 38.10M | 36.30M |
| Other Operating Activities | 8.30M | -21.30M | 5.40M | 22.80M | -18.50M | -13.90M |
| Change in Accounts Receivable | 27.30M | 6.20M | -8.70M | -12.50M | -10.30M | -8.80M |
| Change in Inventory | -3.20M | -3.20M | -6.20M | -1.80M | -2.90M | 1.60M |
| Change in Accounts Payable | -2.10M | -1.40M | 4.70M | -3.70M | -3.50M | 9.20M |
| Change in Unearned Revenue | -26.60M | |||||
| Change in Income Taxes | 12.50M | 4.40M | 500.00K | 700.00K | 700.00K | 89.90M |
| Change in Other Net Operating Assets | -9.50M | -25.30M | -44.70M | 44.30M | -67.50M | 55.50M |
| Operating Cash Flow | 7.70M | 1.80M | -8.70M | -110.90M | -106.30M | 18.60M |
| Capital Expenditures | -15.00M | -15.60M | -19.00M | -63.20M | -45.30M | -18.00M |
| Cash Acquisitions | -57.20M | |||||
| Divestitures | 8.80M | 379.10M | ||||
| Sale (Purchase) of Intangibles | -6.90M | -11.80M | -10.70M | -10.10M | ||
| Investment in Securities | 9.00M | 105.20M | 25.00M | -86.70M | ||
| Investing Cash Flow | -21.90M | -27.40M | -11.90M | 31.90M | -77.50M | 274.40M |
| Long-Term Debt Issued | 165.00M | 120.00M | 80.00M | |||
| Total Debt Issued | 125.00M | 165.00M | 120.00M | 80.00M | ||
| Long-Term Debt Repaid | -80.50M | -119.50M | -40.00M | -226.40M | ||
| Total Debt Repaid | -60.10M | -80.50M | -119.50M | -40.00M | -226.40M | |
| Net Debt Issued (Repaid) | 64.90M | 84.50M | 500.00K | 40.00M | -226.40M | |
| Issuance of Common Stock | 3.40M | 3.30M | 5.90M | 123.60M | 6.30M | 91.80M |
| Repurchase of Common Stock | -4.80M | -7.30M | -13.40M | -8.80M | -10.60M | -11.50M |
| Other Financing Activities | -16.30M | -16.30M | -400.00K | -1.90M | -3.70M | -4.50M |
| Financing Cash Flow | 47.20M | 64.20M | -7.40M | 152.90M | -8.00M | -150.60M |
| Foreign Exchange Rate Adjustments | 100.00K | 800.00K | -1.00M | 600.00K | -600.00K | -600.00K |
| Net Cash Flow | 33.10M | 39.40M | -29.00M | 74.50M | -192.40M | 141.80M |
| Free Cash Flow | -7.30M | -13.80M | -27.70M | -174.10M | -151.60M | 600.00K |
| Free Cash Flow Margin | -0.91% | -1.67% | -3.31% | -23.11% | -22.35% | 0.09% |
| Free Cash Flow Per Share | -0.08 | -0.15 | -0.31 | -2.10 | -1.88 | 0.01 |
| Levered Free Cash Flow | 18.19M | 762.50K | 13.25M | -59.29M | -115.71M | 149.49M |
| Unlevered Free Cash Flow | 28.44M | 7.33M | 15.00M | -57.48M | -113.71M | 153.61M |
| Cash Interest Paid | 13.30M | 8.40M | 1.90M | 1.40M | 4.40M | |
| Cash Income Tax Paid | 1.80M | -85.40M | ||||
| Change in Working Capital | 25.00M | -19.30M | -54.40M | 27.00M | -83.50M | 120.80M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 569.12M | 573.26M | 1.25B | 1.70B | 1.18B | 2.20B |
| Enterprise Value | 664.42M | 640.16M | 1.29B | 1.81B | 1.05B | 1.88B |
| Last Close Price | 6.35 | 6.15 | 13.71 | 19.14 | 14.51 | 27.60 |
| Forward PE | 196.49 | 141.34 | 247.70 | 230.87 | 139.81 | |
| PS Ratio | 0.75 | 0.69 | 1.49 | 2.25 | 1.73 | 3.19 |
| PB Ratio | 2.00 | 1.56 | 1.78 | 2.17 | 1.33 | 2.28 |
| P/TBV Ratio | 5.16 | 3.52 | 8.19 | 11.98 | 5.54 | 6.93 |
| P/FCF Ratio | 3,673.31 | |||||
| P/OCF Ratio | 78.88 | 318.48 | 118.49 | |||
| PEG Ratio | 1.98 | 2.02 | 2.62 | 2.62 | 2.62 | |
| EV/Sales Ratio | 0.87 | 0.78 | 1.54 | 2.41 | 1.55 | 2.73 |
| EV/FCF Ratio | 3,139.65 | |||||
| Debt / Equity Ratio | 0.69 | 0.57 | 0.20 | 0.19 | 0.16 | 0.10 |
| Debt / EBITDA Ratio | 65.56 | |||||
| Debt / FCF Ratio | 153.83 | |||||
| Net Debt / Equity Ratio | 0.31 | 0.16 | 0.05 | 0.01 | -0.03 | -0.32 |
| Net Debt / EBITDA Ratio | -2.37 | -4.27 | -1.41 | -0.14 | 0.35 | 4.78 |
| Net Debt / FCF Ratio | -13.05 | -4.36 | -1.37 | -0.06 | 0.16 | -509.17 |
| Asset Turnover | 1.23 | 0.95 | 0.77 | 0.64 | 0.54 | 0.50 |
| Inventory Turnover | 8.48 | 8.53 | 10.19 | 11.22 | 11.41 | 9.32 |
| Quick Ratio | 1.72 | 1.98 | 1.36 | 1.64 | 1.58 | 2.10 |
| Current Ratio | 2.21 | 2.49 | 1.82 | 2.01 | 2.00 | 2.37 |
| Return on Equity (ROE) | -32.54% | -68.45% | -17.15% | -31.55% | -12.08% | -2.94% |
| Return on Assets (ROA) | -8.60% | -4.89% | -5.06% | -7.71% | -6.14% | -5.78% |
| Return on Invested Capital (ROIC) | -21.97% | -11.62% | -11.48% | -16.91% | -15.11% | -14.56% |
| Return on Capital Employed (ROCE) | -17.80% | -11.80% | -10.20% | -14.60% | -11.70% | -11.30% |
| Earnings Yield | -20.22% | -63.83% | -10.20% | -15.52% | -9.53% | -1.23% |
| FCF Yield | -1.20% | -2.41% | -2.22% | -10.26% | -12.89% | 0.03% |
| Buyback Yield / Dilution | -2.46% | -2.21% | -9.42% | -2.73% | -3.33% | -4.31% |